EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Missense substitutions in the BTB domain of ZBTB24 can lead to protein instability and cause ICF2 syndrome

Or Givol iD, Ido S Han iD, Francesco Cecere, Liran Giladi, Noa Dotan-Glick iD, Revital Shemer, Atar Lev, Amos J Simon, Nivin Moustafa-Hawash, Chen Itzkovich, Vered Schichter-Konfino, Raz Somech und 5 weitere

Human Molecular Genetics · 2026

DOI: 10.1093/hmg/ddaf182 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Human Molecular Genetics, 2026. Verfasst von Or Givol und 16 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Department, Hillel-Yaffe Medical Center, Hashalom Street, Hedera 38100, Israel. Hauptthemen laut MEDLINE: Mutation, Missense, Repressor Proteins, Primary Immunodeficiency Diseases, Face. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ZBTB24 is a member of a protein family containing a Broad-Complex, Tramtrack, and Bric a Brac (BTB) domain, which functions in protein–protein interactions. ZBTB24, a transcription factor, binds its DNA targets through its C-terminal zinc finger (ZF) domain. Biallelic ZBTB24 pathogenic variants lead to the rare autosomal recessive Immunodeficiency, Centromeric instability and Facial anomalies type 2 (ICF2) syndrome. The majority of ICF2 patients carry biallelic loss-of-function variants in ZBTB24. The remaining patients harbor missense variants in the ZF domain that compromise the ability of ZBTB24 to transcriptionally activate CDCA7, the gene responsible for ICF subtype 3 syndrome. Although an ICF2 patient with compound heterozygous pathogenic variants, including a missense variant (p.Ser59Gly) in the BTB domain, has been reported, no ICF2 patients with biallelic missense variants in any ZBTB24 domains other than the zinc finger domain have been described. Similar to all subtypes of ICF syndrome, ZBTB24 pathogenic variants lead to significant DNA hypomethylation throughout the genome. Here we describe a patient with severe infections initiating during her first year of life, significant developmental delay and an abnormal facial shape, who carries a homozygous p.Val43Leu substitution in the BTB domain of ZBTB24. The patient’s peripheral blood cells demonstrate whole genome DNA hypomethylation with patterns identical to those found in verified ICF2 patients. Both the p.Val43Leu and p.Ser59Gly variants cause significant ZBTB24 protein instability. Thus, we demonstrate that pathogenic missense variants in the BTB domain of ZBTB24 can functionally act as loss-of-function variants that result in ICF2 syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mutation, MissenseRepressor ProteinsPrimary Immunodeficiency DiseasesFaceImmunologic Deficiency SyndromesHumansFemaleProtein StabilityMaleProtein DomainsZinc FingersDNA MethylationNuclear Proteins

Stichwörter der Autor:innen

BTB domainDNA methylationICF2 syndromeZBTB24

Substanzen

ZBTB24 protein, humanRepressor ProteinsCDCA7 protein, humanNuclear Proteins

Autor:innen und Institutionen

  • Pediatric Department, Hillel-Yaffe Medical Center, Hashalom Street, Hedera 38100, Israel.
  • Department of Genetics and Developmental Biology, B. Rappaport Faculty of Medicine, Technion-I.I.T., 1 Efron Street, Haifa 31096, Israel.
  • Department of Biomedical Sciences, Institute of Genetics and Biophysics "Adriano Buzzati-Traverso", Consiglio Nazionale delle Ricerche (CNR), Via Pietro Castellino 111, Naples 80131, Italy.
  • Pediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Ramat-Gan 5262000, Israel.
  • Hemato-Immunology Unit, Hematology Lab and Sheba Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat-Gan, 5262000, Israel.
  • The Genetics Institute, Rambam Health Care Campus, 8 HaAliya HaShniya Street, Haifa 35254, Israel.

ORCID-Profile: Or Givol, Ido S Han, Noa Dotan-Glick, Motoko Unoki, Sara Selig

Förderung

  • Israel Science Foundation

Zitieren

APA

Givol, O., Han, I. S., Cecere, F., Giladi, L., Dotan-Glick, N., Shemer, R., Lev, A., Simon, A. J., Moustafa-Hawash, N., Itzkovich, C., Schichter-Konfino, V., Somech, R., Weiss, K., Kornitzer, D., Unoki, M., Matarazzo, M. R., & Selig, S. (2026). Missense substitutions in the BTB domain of ZBTB24 can lead to protein instability and cause ICF2 syndrome. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf182

Vancouver

Givol O, Han IS, Cecere F, Giladi L, Dotan-Glick N, Shemer R, et al. Missense substitutions in the BTB domain of ZBTB24 can lead to protein instability and cause ICF2 syndrome. Human Molecular Genetics. 2026. doi:10.1093/hmg/ddaf182

BibTeX
@article{Givol2026,
  author = {Givol, Or and Han, Ido S and Cecere, Francesco and Giladi, Liran and Dotan-Glick, Noa and Shemer, Revital and Lev, Atar and Simon, Amos J and Moustafa-Hawash, Nivin and Itzkovich, Chen and Schichter-Konfino, Vered and Somech, Raz and Weiss, Karin and Kornitzer, Daniel and Unoki, Motoko and Matarazzo, Maria Rosaria and Selig, Sara},
  title = {Missense substitutions in the BTB domain of ZBTB24 can lead to protein instability and cause ICF2 syndrome},
  journal = {Human Molecular Genetics},
  year = {2026},
  doi = {10.1093/hmg/ddaf182}
}
Kostenlos starten →